J, S. M. PHARMACOKINETICS OF SECOND LINE ANTI-TB DRUG (LEVOFLOXACIN) IN MDR-TB PATIENTS. Scholar: National School of Leadership, [S. l.], v. 8, n. 2.2, 2019. Disponível em: https://jconsortium.com/index.php/scholar/article/view/93. Acesso em: 6 nov. 2024.